| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | +65.5% |
| Cost of Revenue | $782K | +103.2% |
| Gross Profit | $224K | +0.4% |
| R&D Expense | $2.1M | -57.8% |
| SG&A Expense | $6.3M | +25.0% |
| Operating Income | -$7.8M | +20.1% |
| Pre-tax Income | -$7.4M | +7.4% |
| Income Tax | $0 | -100.0% |
| Net Income | -$7.4M | +7.3% |
| EPS (Basic) | -$11.73 | +36.8% |
| EPS (Diluted) | -$11.73 | +36.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -9.0% |
| Short-term Investments | $1.2M | -28.2% |
| Accounts Receivable | $510K | +4.7% |
| Inventory | $657K | +48.4% |
| Current Assets | $4.9M | -9.1% |
| Total Assets | $5.4M | -6.8% |
| Current Liabilities | $1.8M | +11.2% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | -21.3% |
| Capital Expenditures | $140K | +34.8% |
| Investing Cash Flow | $255K | +113.5% |
| Financing Cash Flow | $6.4M | -8.7% |
| Free Cash Flow | -$7.0M | -21.5% |
| $150K |
| +0.0% |
| Total Liabilities | $2.0M | +10.1% |
| Stockholders' Equity | $3.5M | -14.2% |